摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2Z)-2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-ylidene)-N-(furan-2-ylmethyl)-N-methylacetamide | 1232682-43-7

中文名称
——
中文别名
——
英文名称
(2Z)-2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-ylidene)-N-(furan-2-ylmethyl)-N-methylacetamide
英文别名
——
(2Z)-2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-ylidene)-N-(furan-2-ylmethyl)-N-methylacetamide化学式
CAS
1232682-43-7
化学式
C13H15NO5
mdl
——
分子量
265.266
InChiKey
PKSSJHLJBLEPHW-YFHOEESVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    69
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    (2Z)-2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-ylidene)-N-(furan-2-ylmethyl)-N-methylacetamide 在 sodium hydroxide 作用下, 以 为溶剂, 以95%的产率得到3-(Furan-2-ylmethyl-methyl-carbamoyl)-2-hydroxy-acrylic acid
    参考文献:
    名称:
    (Z)-2,2-Dimethyl-5-carboxymethylene-1,3-dioxolan-4-one: a new synthon for the synthesis of α,γ-diketoacid derivatives
    摘要:
    The synthesis and reactivity of (Z)-2,2-dimethyl-5-carboxymethylene-1,3-dioxolan-4-one, a new and versatile synthon useful for the synthesis of selectively protected alpha,gamma-diketoacid derivatives, are described. This new, protected form of hydroxyl fumaric acid along with its acid chloride was used to prepare ester, amide, and aryl derivatives. The dioxolane moiety was found to be a convenient functionality that facilitated ready unmasking by straightforward hydrolysis to reveal alpha,gamma-diketoacid derivatives or derivatization to yield ester, amide, and 2,3-pyrrolidinedione derivatives. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2010.04.032
  • 作为产物:
    描述:
    N-甲基糠基胺(Z)-2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-ylidene)acetic acid 在 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 三乙胺 作用下, 以 乙腈 为溶剂, 以90%的产率得到(2Z)-2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-ylidene)-N-(furan-2-ylmethyl)-N-methylacetamide
    参考文献:
    名称:
    (Z)-2,2-Dimethyl-5-carboxymethylene-1,3-dioxolan-4-one: a new synthon for the synthesis of α,γ-diketoacid derivatives
    摘要:
    The synthesis and reactivity of (Z)-2,2-dimethyl-5-carboxymethylene-1,3-dioxolan-4-one, a new and versatile synthon useful for the synthesis of selectively protected alpha,gamma-diketoacid derivatives, are described. This new, protected form of hydroxyl fumaric acid along with its acid chloride was used to prepare ester, amide, and aryl derivatives. The dioxolane moiety was found to be a convenient functionality that facilitated ready unmasking by straightforward hydrolysis to reveal alpha,gamma-diketoacid derivatives or derivatization to yield ester, amide, and 2,3-pyrrolidinedione derivatives. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2010.04.032
点击查看最新优质反应信息

文献信息

  • HIV integrase inhibitors
    申请人:——
    公开号:US20030181490A1
    公开(公告)日:2003-09-25
    The present invention relates to the inhibition of HIV integrase, and to the treatment of AIDS or ARC by administering compounds of the formula 1 wherein R 1 is C 1 -C 4 alkyl, carbocyclic radical, heterocyclic radical, aryl-C 1 -C 2 alkylene, aryloxy-C 1 -C 2 alkylene, alkoxy-CC(O)—, wherein R 1 is optionally substituted from 1-3 times with halo, C 1 -C 2 alkyl or C 1 -C 2 alkoxy, or R 1 is H; R 2 is H or C 1 -C 4 alkyl; R 3 is H, C 1 -C 4 alkyl or phenyl-C 0 -C 2 alkylene which is optionally substituted with 1-3 R 5 ; R 4a is carbocylic radical, heterocyclic radical, aryloxy, aryl-C 1 -C 4 alkylene, aryl-cyclopropylene, aryl-NHC(O)—, wherein R 4a is optionally substituted with 1-3 R 5 ; and wherein each R 5 is independently selected from H, halo, C 1 -C 4 alkyl, C 1 -C 4 alkenyl, C 1 -C 4 haloalkyl, C 1 -C 4 alkoxy, R 6 -phenyl, R 6 -phenoxy, R 6 -benzyl, R 6 -benzyloxy, NH 2 C (O)—, alkyl-NHC(O)—, wherein R 6 is H, halo; Z is a bond or a substituted or unsubstituted C 1 -C 4 alkylene group; and B 2 is 2
    本发明涉及抑制HIV整合酶的化合物,并通过给予式1中的化合物治疗艾滋病或ARC,其中R1为C1-C4烷基,碳环基,杂环基,芳基-C1-C2烷基,芳氧基-C1-C2烷基,烷氧基-CC(O)-,其中R1可以用卤素,C1-C2烷基或C1-C2烷氧基从1-3次取代,或R1为H;R2为H或C1-C4烷基;R3为H,C1-C4烷基或苯基-C0-C2烷基,该苯基-C0-C2烷基可以选择性地用1-3个R5取代;R4a为碳环基,杂环基,芳氧基,芳基-C1-C4烷基,芳基环丙基,芳基-NHC(O)-,其中R4a可以选择性地用1-3个R5取代;每个R5都是独立选择的H,卤素,C1-C4烷基,C1-C4烯基,C1-C4卤代烷基,C1-C4烷氧基,R6-苯基,R6-苯氧基,R6-苄基,R6-苄氧基,NH2C(O)-,烷基-NHC(O)-,其中R6为H,卤素;Z为键或取代或未取代的C1-C4烷基;B2为2。
  • US6803378B2
    申请人:——
    公开号:US6803378B2
    公开(公告)日:2004-10-12
查看更多